ITGAE and neoplasm: Recent studies have indicated that tumor accumulation of rare Batf3-dependent DCs bearing the CD103 marker is associated with good prognosis and immune-mediated control across mouse and human species (Broz et al., 2014; Ruffell et al., 2014).